120 results
8-K
EX-99.1
VANI
Vivani Medical Inc
13 Jun 24
Other Events
8:01am
Exhibit 99.1
Vivani Medical Announces FDA Clears Investigational New Drug
Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term
Subdermal … with oral and injectable type 2 diabetes medications, by providing
long-term therapeutic delivery of exenatide for six months
Study will represent first
8-K
EX-99.1
VANI
Vivani Medical Inc
13 May 24
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
4:57pm
of miniature, long-term GLP-1 implants for the treatment of chronic weight management in obese or overweight patients, type 2 diabetes, and other … miniaturized, long-term drug implants including its lead asset NPM-115 for chronic weight management in obese or overweight patients with one or more risk
8-K
EX-99.2
VANI
Vivani Medical Inc
13 May 24
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
4:57pm
, biopharmaceutical company developing a portfolio of miniature, long-term, drug implants to treat chronic diseases. Our NanoPortal™ platform technology enables … for exenatide and semaglutide NPM-115 target profile may provide an attractive alternative to life-long injections or pills for long-term maintenance
8-K
EX-99.1
i9zc k4yv5a
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
8-K
EX-99.2
tefuxrqu5xtos 037
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
8-K
EX-99.1
gt13iuc09ldoi quu
6 Mar 24
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
8:30am
8-K
EX-99.1
46mi68ijk7om88n d2y5
5 Mar 24
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
4:21pm
424B5
wtvbe2vgygl
5 Mar 24
Prospectus supplement for primary offering
11:31am
8-K
EX-99.2
44khnn1crp56y
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
b6jmw6a
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
EX-99.2
7e6bbnyn
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-99.1
ycd zb59pa
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-99.1
ddzp9pugix1ej
18 Sep 23
Regulation FD Disclosure
6:20am
8-K
EX-99.1
rhqybt4l0gcnl9dg1kn
28 Aug 23
Entry into a Material Definitive Agreement
5:43pm